Uri Ladabaum

4.9/5

23 Patient Ratings

129 Patient Reviews

Uri Ladabaum

Gastroenterologist, Geneticist, Cancer geneticist, General gastroenterologist

Professor of Medicine (Gastroenterology and Hepatology)

View Professional Summary

Additional Languages Spoken:

French , Spanish

Insurance Coverage

Resources for Referring Physicians

Biography

Dr. Uri Ladabaum serves as director of the Gastrointestinal Cancer Prevention Program and heads the Clinical Service of the Division of Gastroenterology and Hepatology at Stanford University School of Medicine. Dr. Ladabaum received his medical degree from the University of California, San Francisco, completed his residency and chief residency in internal medicine at Stanford University Hospital, and fellowship in gastroenterology at the University of Michigan, where he also obtained a M.S. degree in clinical research design and statistical analysis. He returned to the Bay Area in 1999 as a faculty member at the University of California, San Francisco, and joined the Stanford faculty in 2009.

Dr. Ladabaum's research focus is colorectal cancer risk management and prevention, including screening, risk stratification, and management of average-risk as well as high-risk populations, including persons with Lynch syndrome. His clinical efforts include providing consultation and screening and surveillance endoscopic services for average risk and high-risk persons, and caring for patients and families with suspected or established inherited cancer predisposition syndromes, including Lynch syndrome and polyposis syndromes. In addition, Dr. Ladabaum provides general gastroenterology consultation and endoscopic services.

Dr. Ladabaum's research program spans a range of methods and approaches including epidemiological studies, observational and interventional clinical studies, systematic reviews, decision analyses and health economic evaluations. Current efforts include exploring colorectal cancer screening tailored to risk, and enhancing the uptake of genetic testing and preventive interventions.

View Full Biography

Professional Summary

Education & Certifications

Board Certification: American Board of Internal Medicine, Gastroenterology (2024)
Fellowship: University of Michigan (1998) MI
Residency: Stanford University Internal Medicine Residency (1994) CA

Medical Education: University of California at San Francisco School of Medicine (1991) CA

A.B., University of California, Berkeley, Biochemistry (1987)

M.D., University of California, San Francisco, Medicine (1991)

M.S., University of Michigan, Ann Arbor, Clinical Research Design and Statistical Analysis (1999)

Residency, Stanford University Hospital - Internal Medicine, CA (1994)

Chief Residency, Stanford University Hospital - Internal Medicine, CA (1995)

Administrative Appointments

Director, Gastrointestinal Cancer Prevention Program (2009 - Present)
Senior Vice Chief, Division of Gastroenterology and Hepatology (2013 - Present)
Vice Chief, Clinical Service, Division of Gastroenterology and Hepatology (2013 - Present)

Publications

Images in clinical medicine. Barrett's esophagus with high-grade dysplasia.
Ladabaum, U., & Mcdonnell, W. M. (1999). Images in clinical medicine. Barrett's esophagus with high-grade dysplasia. New England Journal of Medicine, 341(19), 1439-?
Novel approaches to the treatment of nausea and vomiting
Ladabaum, U., & Hasler, W. L. (1999). Novel approaches to the treatment of nausea and vomiting. DIGESTIVE DISEASES, 17(3), 125–132.
Pathobiology of visceral pain: Molecular mechanisms and therapeutic implications v. Central nervous system processing of somatic and visceral sensory signals
Ladabaum, U., Minoshima, S., & Owyang, C. (2000). Pathobiology of visceral pain: Molecular mechanisms and therapeutic implications v. Central nervous system processing of somatic and visceral sensory signals. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 279(1), G1–G6.

Gastric distention correlates with activation of multiple cortical and subcortical regions
Ladabaum, U., Minoshima, S., Hasler, W. L., Cross, D., Chey, W. D., & Owyang, C. (2001). Gastric distention correlates with activation of multiple cortical and subcortical regions. GASTROENTEROLOGY, 120(2), 369–376.

Effects of nutrients and serotonin 5-HT3 antagonism on symptoms evoked by distal gastric distension in humans
Ladabaum, U., Brown, M. B., Pan, W. Q., Chung, O. Y., & Hasler, W. L. (2001). Effects of nutrients and serotonin 5-HT3 antagonism on symptoms evoked by distal gastric distension in humans. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 280(2), G201–G208.

Outcomes of initial noninvasive Helicobacter pylori testing in US primary care patients with uninvestigated dyspepsia
Ladabaum, U., Fendrick, A. M., & Scheiman, J. M. (2001). Outcomes of initial noninvasive Helicobacter pylori testing in US primary care patients with uninvestigated dyspepsia. AMERICAN JOURNAL OF GASTROENTEROLOGY, 96(7), 2051–2057.

Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer - A cost-effectiveness analysis
Ladabaum, U., CHOPRA, C. L., Huang, G., Scheiman, J. M., Chernew, M. E., & Fendrick, A. M. (2001). Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer - A cost-effectiveness analysis. ANNALS OF INTERNAL MEDICINE, 135(9), 769–81.

Uninvestigated Dyspepsia.
Ladabaum, U., & Chey, W. D. (2002). Uninvestigated Dyspepsia. Current Treatment Options in Gastroenterology, 5(2), 125–131.

Positron emission tomography: the gastroenterologists's perspective
Ladabaum, U. (2002). Positron emission tomography: the gastroenterologists's perspective. GASTROINTESTINAL ENDOSCOPY, 55(7), S64–S66.

Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis
Ladabaum, U., Chey, W. D., Scheiman, J. M., & Fendrick, A. M. (2002). Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 16(8), 1491–1501.

The yield of lower endoscopy in patients with constipation: survey of a university hospital, a public county hospital, and a Veterans Administration medical center
Pepin, C., & Ladabaum, U. (2002). The yield of lower endoscopy in patients with constipation: survey of a university hospital, a public county hospital, and a Veterans Administration medical center. GASTROINTESTINAL ENDOSCOPY, 56(3), 325–332.

Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans
Ladabaum, U., & Glidden, D. (2002). Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans. NEUROGASTROENTEROLOGY AND MOTILITY, 14(4), 395–401.

Helicobacter pylori test-and-treat intervention compared to usual care in primary care patients with suspected peptic ulcer disease in the United States
Ladabaum, U., Fendrick, A. M., Glidden, D., & Scheiman, J. M. (2002). Helicobacter pylori test-and-treat intervention compared to usual care in primary care patients with suspected peptic ulcer disease in the United States. AMERICAN JOURNAL OF GASTROENTEROLOGY, 97(12), 3007–3014.

Safety, efficacy and costs of pharmacotherapy for functional gastrointestinal disorders: the case of alosetron and its implications
Ladabaum, U. (2003). Safety, efficacy and costs of pharmacotherapy for functional gastrointestinal disorders: the case of alosetron and its implications. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 17(8), 1021–1030.

Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: A cost-effectiveness analysis
Ladabaum, U., Scheiman, J. A., & Fendrick, A. M. (2003). Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: A cost-effectiveness analysis. AMERICAN JOURNAL OF MEDICINE, 114(7), 546–554.

Education does pay off: pneumococcal vaccine screening and administration in hospitalized adult patients with pneumonia.
Kruspe, R., Lillis, R., Daberkow, D. W., Blais, C. M., Wilbright, W., Gupta, S., … Lopez, F. A. (2003). Education does pay off: pneumococcal vaccine screening and administration in hospitalized adult patients with pneumonia. Journal of the Louisiana State Medical Society , 155(6), 325–331.

Fecal DNA testing compared with conventional colorectal cancer screening methods: A decision analysis
Song, K., Fendrick, A. M., & Ladabaum, U. (2004). Fecal DNA testing compared with conventional colorectal cancer screening methods: A decision analysis. GASTROENTEROLOGY, 126(5), 1270–1279.

Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis
Mein, S. M., & Ladabaum, U. (2004). Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 19(11), 1199–1210.

Colorectal Neoplasia Screening With Virtual Colonoscopy: When, at What Cost, and With What National Impact?
Ladabaum, U., Song, K., & Fendrick, A. M. (2004). Colorectal Neoplasia Screening With Virtual Colonoscopy: When, at What Cost, and With What National Impact? CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2(7), 554–563.

Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis
Patel, D., Terrault, N. A., Yao, F. Y., Bass, N. M., & Ladabaum, U. (2005). Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 3(1), 75–84.

Obstipation as a paraneoplastic presentation of small cell lung cancer: case report and literature review
Jun, S., Dimyan, M., Jones, K. D., & Ladabaum, U. (2005). Obstipation as a paraneoplastic presentation of small cell lung cancer: case report and literature review. NEUROGASTROENTEROLOGY AND MOTILITY, 17(1), 16–22.

Sedation for gastrointestinal endoscopy: New practices, new economics
Aisenberg, J., Brill, J. V., Ladabaum, U., & Cohen, L. B. (2005). Sedation for gastrointestinal endoscopy: New practices, new economics. AMERICAN JOURNAL OF GASTROENTEROLOGY, 100(5), 996–1000.

Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand
Ladabaum, U., & Song, K. (2005). Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. GASTROENTEROLOGY, 129(4), 1151–62.

Colorectal cancer screening - Differential costs for younger versus older Americans
Ladabaum, U., & Phillips, K. A. (2006). Colorectal cancer screening - Differential costs for younger versus older Americans. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 30(5), 378–384.

Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin
Wilcox, C. M., Allison, J., Benzuly, K., Borum, M., Cryer, B., Grosser, T., … Simon, L. (2006). Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 4(9), 1082–1089.

A patient with high risk of gastrointestinal bleeding requiring nonsteroidal anti-inflammatory drugs
Wilcox, C. M., & Ladabaum, U. (2006). A patient with high risk of gastrointestinal bleeding requiring nonsteroidal anti-inflammatory drugs. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 4(9), 1090–1093.

Rates and predictors of colorectal cancer screening.
Liang, S.-Y., Phillips, K. A., Nagamine, M., Ladabaum, U., & Haas, J. S. (2006). Rates and predictors of colorectal cancer screening. Preventing Chronic Disease, 3(4), A117-?

Motility of the small intestine
Ladabaum, U., & Hasler, W. L. (1999). Motility of the small intestine. CURRENT OPINION IN GASTROENTEROLOGY, 15(2), 125–131.

Gastric fundic distension activates fronto-limbic structures but not primary somatosensory cortex: A functional magnetic resonance imaging study
Ladabaum, U., Roberts, T. P., & McGonigle, D. J. (2007). Gastric fundic distension activates fronto-limbic structures but not primary somatosensory cortex: A functional magnetic resonance imaging study. NEUROIMAGE, 34(2), 724–732.

Trends in colonoscopy for colorectal cancer screening
Phillips, K. A., Liang, S.-Y., Ladabaum, U., Haas, J., Kerlikowske, K., Lieberman, D., … Van Bebber, S. L. (2007). Trends in colonoscopy for colorectal cancer screening. MEDICAL CARE, 45(2), 160–167.

When even people at high risk do not take up colorectal cancer screening
Ladabaum, U. (2007). When even people at high risk do not take up colorectal cancer screening. GUT, 56(12), 1648–1650.

Colonoscopic treatment of acute diverticular hemorrhage using endoclips
Yen, E. F., Ladabaum, U., Muthusamy, V. R., Cello, J. P., Mcquaid, K. R., & Shah, J. N. (2008). Colonoscopic treatment of acute diverticular hemorrhage using endoclips. DIGESTIVE DISEASES AND SCIENCES, 53(9), 2480–2485.

As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia
Parekh, M., Fendrick, A. M., & Ladabaum, U. (2008). As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 27(8), 697–712.

Cost-Effectiveness of 5-Aminosalicylic Acid Therapy for Maintenance of Remission in Ulcerative Colitis
Yen, E. F., Kane, S. V., & Ladabaum, U. (2008). Cost-Effectiveness of 5-Aminosalicylic Acid Therapy for Maintenance of Remission in Ulcerative Colitis. AMERICAN JOURNAL OF GASTROENTEROLOGY, 103(12), 3094–3105.

Melanosis coli.
Li, D., Browne, L. W., & Ladabaum, U. (2009). Melanosis coli. Clinical Gastroenterology and Hepatology , 7(9), A20-?

Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance?
Shaukat, A., Parekh, M., Lipscomb, J., & Ladabaum, U. (2009). Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance? INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 25(2), 222–231.

Cost Effectiveness of Ulcerative Colitis Surveillance in the Setting of 5-Aminosalicylates
Rubenstein, J. H., Waljee, A. K., Jeter, J. M., Velayos, F. S., Ladabaum, U., & Higgins, P. D. R. (2009). Cost Effectiveness of Ulcerative Colitis Surveillance in the Setting of 5-Aminosalicylates. AMERICAN JOURNAL OF GASTROENTEROLOGY, 104(9), 2222–2232.

Addressing the Challenges of the Clinical Application of Pharmacogenetic Testing
Ikediobi, O. N., Shin, J., Nussbaum, R. L., & Phillips, K. A. (2009). Addressing the Challenges of the Clinical Application of Pharmacogenetic Testing. CLINICAL PHARMACOLOGY & THERAPEUTICS, 86(1), 28–31.

Citalopram Provides Little or No Benefit in Nondepressed Patients With Irritable Bowel Syndrome
Ladabaum, U., Sharabidze, A., Levin, T. R., Zhao, W. K., Chung, E., Bacchetti, P., … Pepin, C. J. (2010). Citalopram Provides Little or No Benefit in Nondepressed Patients With Irritable Bowel Syndrome. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 8(1), 42–48.

Potential cost-effectiveness of colorectal cancer chemoprevention with nonsteroidal anti-inflammatory drugs.
Ladabaum, U. (2003). Potential cost-effectiveness of colorectal cancer chemoprevention with nonsteroidal anti-inflammatory drugs. Expert Review of Pharmacoeconomics & Outcomes Research, 3(6), 757–771.

Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation
Ladabaum, U., Cheng, S. L., Yao, F. Y., & Roberts, J. P. (2011). Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation. CLINICAL TRANSPLANTATION, 25(2), 283–91.

Rate and yield of repeat upper endoscopy in patients with dyspepsia
Ladabaum, U., & Dinh, V. (2010). Rate and yield of repeat upper endoscopy in patients with dyspepsia. WORLD JOURNAL OF GASTROENTEROLOGY, 16(20), 2520–25.

Esophageal verrucous carcinoma arising from hyperkeratotic plaques associated with human papilloma virus type 51
Tonna, J., Palefsky, J. M., Rabban, J., Campos, G. M., Theodore, P., & Ladabaum, U. (2010). Esophageal verrucous carcinoma arising from hyperkeratotic plaques associated with human papilloma virus type 51. DISEASES OF THE ESOPHAGUS, 23(5), E17–E20.

Cost-Effectiveness of Colorectal Cancer Screening in High-Risk Spanish Patients: Use of a Validated Model to Inform Public Policy
Ladabaum, U., Ferrandez, A., & Lanas, A. (2010). Cost-Effectiveness of Colorectal Cancer Screening in High-Risk Spanish Patients: Use of a Validated Model to Inform Public Policy. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 19(11), 2765–76.

The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps
Rex, D. K., Kahi, C., O'Brien, M., Levin, T. R., Pohl, H., Rastogi, A., … Lieberman, D. A. (2011). The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps. GASTROINTESTINAL ENDOSCOPY, 73(3), 419–422.

Economic evaluation of targeted cancer interventions: Critical review and recommendations
Elkin, E. B., Marshall, D. A., Kulin, N. A., Ferrusi, I. L., Hassett, M. J., Ladabaum, U., & Phillips, K. A. (2011). Economic evaluation of targeted cancer interventions: Critical review and recommendations. GENETICS IN MEDICINE, 13(10), 853–860.

Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer A Cost-Effectiveness Analysis
Ladabaum, U., Wang, G., Terdiman, J., Blanco, A., Kuppermann, M., Boland, C. R., … Phillips, K. A. (2011). Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer A Cost-Effectiveness Analysis. ANNALS OF INTERNAL MEDICINE, 155(2), 69–U50.

Diagnosis, Comorbidities, and Management of Irritable Bowel Syndrome in Patients in a Large Health Maintenance Organization
Ladabaum, U., Boyd, E., Zhao, W. K., Mannalithara, A., Sharabidze, A., Singh, G., … Levin, T. R. (2012). Diagnosis, Comorbidities, and Management of Irritable Bowel Syndrome in Patients in a Large Health Maintenance Organization. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 10(1), 37–45.

Disparities in cancer screening in individuals with a family history of breast or colorectal cancer
Ponce, N. A., Tsui, J., Knight, S. J., Afable-Munsuz, A., Ladabaum, U., Hiatt, R. A., & Haas, J. S. (2012). Disparities in cancer screening in individuals with a family history of breast or colorectal cancer. CANCER, 118(6), 1656–1663.

Cancer-Associated Aorto-Enteric Fistula
Singh, S., Ladabaum, U., Hovsepian, D. M., & Triadafilopoulos, G. (2012). Cancer-Associated Aorto-Enteric Fistula. DIGESTIVE DISEASES AND SCIENCES, 57(3), 625–29.

Preferences for Genetic Testing to Identify Hereditary Colorectal Cancer: Perspectives of High-Risk Patients, Community Members, and Clinicians
Walsh, J., Arora, M., Hosenfeld, C., Ladabaum, U., Kuppermann, M., & Knight, S. J. (2012). Preferences for Genetic Testing to Identify Hereditary Colorectal Cancer: Perspectives of High-Risk Patients, Community Members, and Clinicians. JOURNAL OF CANCER EDUCATION, 27(1), 112–19.

Influence of Patient Preferences on the Cost-Effectiveness of Screening for Lynch Syndrome
Wang, G., Kuppermann, M., Kim, B., Phillips, K. A., & Ladabaum, U. (2012). Influence of Patient Preferences on the Cost-Effectiveness of Screening for Lynch Syndrome. AMERICAN JOURNAL OF MANAGED CARE, 18(5), E179–U2.

Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome
Kuppermann, M., Wang, G., Wong, S., Blanco, A., Conrad, P., Nakagawa, S., … Ladabaum, U. (2013). Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome. CANCER, 119(1), 215–225.

Cost analysis of a patient navigation system to increase screening colonoscopy adherence among urban minorities
Jandorf, L., Stossel, L. M., Cooperman, J. L., Zivin, J. G., Ladabaum, U., Hall, D., … Itzkowitz, S. H. (2013). Cost analysis of a patient navigation system to increase screening colonoscopy adherence among urban minorities. CANCER, 119(3), 612–620.

Proximal and Distal Colorectal Cancer Resection Rates in the United States Since Widespread Screening by Colonoscopy
Myer, P. A., Mannalithara, A., Singh, G., & Ladabaum, U. (2012). Proximal and Distal Colorectal Cancer Resection Rates in the United States Since Widespread Screening by Colonoscopy. GASTROENTEROLOGY, 143(5), 1227–36.

An Uncommon Complication of Percutaneous Endoscopic Gastrostomy Tubes
Wong, R., & Ladabaum, U. (2013). An Uncommon Complication of Percutaneous Endoscopic Gastrostomy Tubes. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 11(2), XXV-XXV.

Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome.
Wang, G., Kuppermann, M., Kim, B., Phillips, K. A., & Ladabaum, U. (2012). Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome. Journal of Oncology Practice / American Society of Clinical Oncology, 8(3), e24s–30s.

Real-Time Optical Biopsy of Colon Polyps With Narrow Band Imaging in Community Practice Does Not Yet Meet Key Thresholds for Clinical Decisions
Ladabaum, U., Fioritto, A., Mitani, A., Desai, M., Kim, J. P., Rex, D. K., … Gunaratnam, N. (2013). Real-Time Optical Biopsy of Colon Polyps With Narrow Band Imaging in Community Practice Does Not Yet Meet Key Thresholds for Clinical Decisions. GASTROENTEROLOGY, 144(1), 81–91.

Lynch Syndrome in Patients With Colorectal Cancer Finding the Needle in the Haystack
Ladabaum, U., & Ford, J. M. (2012). Lynch Syndrome in Patients With Colorectal Cancer Finding the Needle in the Haystack. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 308(15), 1581–83.

How to value technological innovation: a proposal for determining relative clinical value.
Ladabaum, U., Brill, J. V., Sonnenberg, A., Shaheen, N. J., Inadomi, J., Wilcox, C. M., … Pasricha, P. J. (2013). How to value technological innovation: a proposal for determining relative clinical value. Gastroenterology, 144(1), 5–8.

Comparative Effectiveness and Cost-Effectiveness of Screening Colonoscopy vs. Sigmoidoscopy and Alternative Strategies
Sharaf, R. N., & Ladabaum, U. (2013). Comparative Effectiveness and Cost-Effectiveness of Screening Colonoscopy vs. Sigmoidoscopy and Alternative Strategies. AMERICAN JOURNAL OF GASTROENTEROLOGY, 108(1), 120–32.

Health Benefits and Cost-effectiveness of a Hybrid Screening Strategy for Colorectal Cancer
Tuan Dinh, T., Ladabaum, U., Alperin, P., Caldwell, C., Smith, R., & Levin, T. R. (2013). Health Benefits and Cost-effectiveness of a Hybrid Screening Strategy for Colorectal Cancer. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 11(9), 1158–66.

Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review.
Sharaf, R. N., Myer, P., Stave, C. D., Diamond, L. C., & Ladabaum, U. (2013). Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review. Clinical Gastroenterology and Hepatology , 11(9), 1093–1100.

Differential symptomatic and electrogastrographic effects of distal and proximal human gastric distension
Ladabaum, U., Koshy, S. S., Woods, M. L., Hooper, F. G., Owyang, C., & Hasler, W. L. (1998). Differential symptomatic and electrogastrographic effects of distal and proximal human gastric distension. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 275(3), G418–G424.

Differential 5-HT3 mediation of human gastrocolonic response and colonic peristaltic reflex
Bjornsson, E. S., Chey, W. D., Ladabaum, U., Woods, M. L., Hooper, F. G., Owyang, C., & Hasler, W. L. (1998). Differential 5-HT3 mediation of human gastrocolonic response and colonic peristaltic reflex. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 275(3), G498–G505.

Potential population-wide impact of aspirin on colon cancer mortality
Ladabaum, U., & Sowers, M. (1998). Potential population-wide impact of aspirin on colon cancer mortality. GASTROENTEROLOGY, 115(2), 514–515.

American gastroenterological association technical review on the evaluation of dyspepsia
Allison, J. A., Inadomi, J. M., Ladabaum, U., McQuaid, K., & Metz, D. (2005). American gastroenterological association technical review on the evaluation of dyspepsia. GASTROENTEROLOGY, 129(5), 1756–1780.

Colorectal Cancer Screening with Blood-Based Biomarkers: Cost-Effectiveness of Methylated Septin 9 DNA versus Current Strategies
Ladabaum, U., Allen, J., Wandell, M., & Ramsey, S. (2013). Colorectal Cancer Screening with Blood-Based Biomarkers: Cost-Effectiveness of Methylated Septin 9 DNA versus Current Strategies. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 22(9), 1567–76.

Optical biopsy of sessile serrated adenomas: do these lesions resemble hyperplastic polyps under narrow-band imaging?
Kumar, S., Fioritto, A., Mitani, A., Desai, M., Gunaratnam, N., & Ladabaum, U. (2013). Optical biopsy of sessile serrated adenomas: do these lesions resemble hyperplastic polyps under narrow-band imaging? Gastrointestinal Endoscopy, 78(6), 902–9.

Clinical and economic burden of emergency department visits due to gastrointestinal diseases in the United States.
Myer, P. A., Mannalithara, A., Singh, G., Singh, G., Pasricha, P. J., & Ladabaum, U. (2013). Clinical and economic burden of emergency department visits due to gastrointestinal diseases in the United States. American Journal of Gastroenterology, 108(9), 1496–1507.

Locally advanced gastric cancer complicated by mesenteric invasion and intestinal malrotation.
Huang, R. J., Visser, B. C., Chen, A. M., & Ladabaum, U. (2014). Locally advanced gastric cancer complicated by mesenteric invasion and intestinal malrotation. Digestive Diseases and Sciences, 59(2), 267–69.

Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment
Kurian, A. W., Hare, E. E., Mills, M. A., Kingham, K. E., McPherson, L., Whittemore, A. S., … Ford, J. M. (2014). Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment. JOURNAL OF CLINICAL ONCOLOGY, 32(19), 2001–9.

The MLH1 c.-27C>A and c.85G>T variants are linked to dominantly inherited MLH1 epimutation and are borne on a European ancestral haplotype.
Kwok, C.-T., Vogelaar, I. P., van Zelst-Stams, W. A., Mensenkamp, A. R., Ligtenberg, M. J., Rapkins, R. W., … Hitchins, M. P. (2014). The MLH1 c.-27C>A and c.85G>T variants are linked to dominantly inherited MLH1 epimutation and are borne on a European ancestral haplotype. European Journal of Human Genetics , 22(5), 617–24.

Colorectal Cancer Incidence in Asian Populations in California: Effect of Nativity and Neighborhood-Level Factors
Ladabaum, U., Clarke, C. A., Press, D. J., Mannalithara, A., Myer, P. A., Cheng, I., & Gomez, S. L. (2014). Colorectal Cancer Incidence in Asian Populations in California: Effect of Nativity and Neighborhood-Level Factors. AMERICAN JOURNAL OF GASTROENTEROLOGY, 109(4), 579–88.

Barrett's esophagus with high-grade dysplasia
Ladabaum, U., & Mcdonnell, W. M. (1999). Barrett's esophagus with high-grade dysplasia. NEW ENGLAND JOURNAL OF MEDICINE, 341(19), 1439–1439.

Uptake of Genetic Testing by Relatives of Lynch Syndrome Probands: A Systematic Review
Sharaf, R. N., Myer, P., Stave, C. D., Diamond, L. C., & Ladabaum, U. (2013). Uptake of Genetic Testing by Relatives of Lynch Syndrome Probands: A Systematic Review. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 11(9), 1093–1100.

Response:.
Kumar, S., Gunaratnam, N., & Ladabaum, U. (2014). Response:. Gastrointestinal Endoscopy, 79(6), 1031–32.

Obesity, Abdominal Obesity, Physical Activity, and Caloric Intake in US Adults: 1988 to 2010.
Ladabaum, U., Mannalithara, A., Myer, P. A., & Singh, G. (2014). Obesity, Abdominal Obesity, Physical Activity, and Caloric Intake in US Adults: 1988 to 2010. American Journal of Medicine, 127(8), 717–27 e12.

Response to Molakatalla and Kumar.
Ladabaum, U., Clarke, C. A., Cheng, I., & Gomez, S. L. (2014). Response to Molakatalla and Kumar. American Journal of Gastroenterology, 109(10), 1687-?

Colorectal Cancer Mortality Among Hispanics in California: Differences by Neighborhood Socioeconomic Status and Nativity
Tao, L., Ladabaum, U., Gomez, S. L., & Cheng, I. (2014). Colorectal Cancer Mortality Among Hispanics in California: Differences by Neighborhood Socioeconomic Status and Nativity. CANCER, 120(22), 3510–18.

The reply.
Ladabaum, U., Mannalithara, A., Myer, P. A., & Singh, G. (2014). The reply. American Journal of Medicine, 127(12).

Cost-Effectiveness of Patient Navigation to Increase Adherence With Screening Colonoscopy Among Minority Individuals
Ladabaum, U., Mannalithara, A., Jandorf, L., & Itzkowitz, S. H. (2015). Cost-Effectiveness of Patient Navigation to Increase Adherence With Screening Colonoscopy Among Minority Individuals. CANCER, 121(7), 1088–97.

Evaluating the utilization of educational materials in communicating about Lynch syndrome to at-risk relatives
Dilzell, K., Kingham, K., Ormond, K., & Ladabaum, U. (2014). Evaluating the utilization of educational materials in communicating about Lynch syndrome to at-risk relatives. FAMILIAL CANCER, 13(3), 381–89.

Personalizing Colorectal Cancer Screening: A Systematic Review of Models to Predict Risk of Colorectal Neoplasia
Ma, G. K., & Ladabaum, U. (2014). Personalizing Colorectal Cancer Screening: A Systematic Review of Models to Predict Risk of Colorectal Neoplasia. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 12(10), 1624–U84.

Cost-effectiveness of colorectal cancer screening in Germany: current endoscopic and fecal testing strategies versus plasma methylated Septin 9 DNA.
Ladabaum, U., Alvarez-Osorio, L., Rösch, T., & Brueggenjuergen, B. (2014). Cost-effectiveness of colorectal cancer screening in Germany: current endoscopic and fecal testing strategies versus plasma methylated Septin 9 DNA. Endoscopy International Open, 2(2), E96–E104.

The reply.
Ladabaum, U., Mannalithara, A., Myer, P. A., & Singh, G. (2015). The reply. American Journal of Medicine, 128(5).

Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample
Knight, S. J., Mohamed, A. F., Marshall, D. A., Ladabaum, U., Phillips, K. A., & Walsh, J. M. E. (2015). Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample. MEDICAL DECISION MAKING, 35(6), 734–744.

American Gastroenterological Association Technical Review on the Diagnosis and Management of Lynch Syndrome.
Ladabaum, U., Ford, J. M., Martel, M., & Barkun, A. N. (2015). American Gastroenterological Association Technical Review on the Diagnosis and Management of Lynch Syndrome. Gastroenterology, 149(3), 783–813 e20.

Colorectal testing utilization and payments in a large cohort of commercially insured US adults.
Ladabaum, U., Levin, Z., Mannalithara, A., Brill, J. V., & Bundorf, M. K. (2014). Colorectal testing utilization and payments in a large cohort of commercially insured US adults. American Journal of Gastroenterology, 109(10), 1513–25.

Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review
Douglas, M. P., Ladabaum, U., Pletcher, M. J., Marshall, D. A., & Phillips, K. A. (2016). Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review. GENETICS IN MEDICINE, 18(2), 111–16.

Feasibility and Usability Pilot Study of a Novel Irritable Bowel Syndrome Food and Gastrointestinal Symptom Journal Smartphone App
Zia, J., Schroeder, J., Munson, S., Fogarty, J., Nguyen, L., Barney, P., … Ladabaum, U. (2016). Feasibility and Usability Pilot Study of a Novel Irritable Bowel Syndrome Food and Gastrointestinal Symptom Journal Smartphone App. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 7.

Predicting advanced neoplasia at colonoscopy in a diverse population with the National Cancer Institute colorectal cancer risk-assessment tool.
Ladabaum, U., Patel, A., Mannalithara, A., Sundaram, V., Mitani, A., & Desai, M. (2016). Predicting advanced neoplasia at colonoscopy in a diverse population with the National Cancer Institute colorectal cancer risk-assessment tool. Cancer, 122(17), 2663–70.

Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
Ladabaum, U., & Mannalithara, A. (2016). Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia. Gastroenterology, 151(3), 427–39 e6.

Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review.
Lowery, J. T., Ahnen, D. J., Schroy, P. C., Hampel, H., Baxter, N., Boland, C. R., … Smith, R. (2016). Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review. Cancer, 122(17), 2633–45.

Risks and Predictors of Gastric Adenocarcinoma in Patients with Gastric Intestinal Metaplasia and Dysplasia: A Population-Based Study.
Li, D., Bautista, M. C., Jiang, S.-F., Daryani, P., Brackett, M., Armstrong, M. A., … Ladabaum, U. (2016). Risks and Predictors of Gastric Adenocarcinoma in Patients with Gastric Intestinal Metaplasia and Dysplasia: A Population-Based Study. American Journal of Gastroenterology, 111(8), 1104–13.

Advanced-Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis.
Chen, F. W., Sundaram, V., Chew, T. A., & Ladabaum, U. (2016). Advanced-Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis. Clinical Gastroenterology and Hepatology .

Adenoma miss rates associated with a 3-minute versus 6-minute colonoscopy withdrawal time: a prospective, randomized trial.
Kumar, S., Thosani, N., Ladabaum, U., Friedland, S., Chen, A. M., Kochar, R., & Banerjee, S. (2016). Adenoma miss rates associated with a 3-minute versus 6-minute colonoscopy withdrawal time: a prospective, randomized trial. Gastrointestinal Endoscopy.

Screening for Colorectal Cancer and Evolving Issues for Physicians and Patients A Review
Lieberman, D., Ladabaum, U., Cruz-Correa, M., Ginsburg, C., Inadomi, J. M., Kim, L. S., … Wender, R. C. (2016). Screening for Colorectal Cancer and Evolving Issues for Physicians and Patients A Review. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 316(20), 2135–45.

Increased Post-procedural Non-Gastrointestinal Adverse Events After Outpatient Colonoscopy in High-Risk Patients.
Johnson, D. A., Lieberman, D., Inadomi, J. M., Ladabaum, U., Becker, R. C., Gross, S. A., … Robertson, D. J. (2016). Increased Post-procedural Non-Gastrointestinal Adverse Events After Outpatient Colonoscopy in High-Risk Patients. Clinical Gastroenterology and Hepatology .

Advanced-Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis
Chen, F. W., Sundaram, V., Chew, T. A., & Ladabaum, U. (2017). Advanced-Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 15(5), 728-?

Risk stratification of individuals with low-risk colorectal adenomas using clinical characteristics: a pooled analysis
Gupta, S., Jacobs, E. T., Baron, J. A., Lieberman, D. A., Murphy, G., Ladabaum, U., … Martinez, M. E. (2017). Risk stratification of individuals with low-risk colorectal adenomas using clinical characteristics: a pooled analysis. GUT, 66(3), 446–53.

Using Social Media to Characterize Public Sentiment Toward Medical Interventions Commonly Used for Cancer Screening: An Observational Study.
Metwally, O., Blumberg, S., Ladabaum, U., & Sinha, S. R. (2017). Using Social Media to Characterize Public Sentiment Toward Medical Interventions Commonly Used for Cancer Screening: An Observational Study. Journal of Medical Internet Research, 19(6).

Screening for Cancer Genetic Syndromes With a Simple Risk-Assessment Tool in a Community-Based Open-Access Colonoscopy Practice
Gunaratnam, N. T., Akce, M., Al Natour, R., Bartley, A. N., Fioritto, A. F., Hanson, K., & Ladabaum, U. (2016). Screening for Cancer Genetic Syndromes With a Simple Risk-Assessment Tool in a Community-Based Open-Access Colonoscopy Practice. AMERICAN JOURNAL OF GASTROENTEROLOGY, 111(5), 589–93.

Post-Polypectomy Surveillance That Would Please Goldilocks-Not Too Much, Not Too Little, but Just Right
Ladabaum, U., & Schoen, R. E. (2016). Post-Polypectomy Surveillance That Would Please Goldilocks-Not Too Much, Not Too Little, but Just Right. GASTROENTEROLOGY, 150(4), 791–96.

Where Do We Stand With Aspirin for the Prevention of Colorectal Cancer? The USPSTF Recommendations
Chan, A. T., & Ladabaum, U. (2016). Where Do We Stand With Aspirin for the Prevention of Colorectal Cancer? The USPSTF Recommendations. GASTROENTEROLOGY, 150(1), 14–18.

Is the "$1000 Genome" really $1000? Understanding the full benefits and costs of genomic sequencing
Phillips, K. A., Pletcher, M. J., & Ladabaum, U. (2015). Is the "$1000 Genome" really $1000? Understanding the full benefits and costs of genomic sequencing. TECHNOLOGY AND HEALTH CARE, 23(3), 373–79.

Patient communication of cancer genetic test results in a diverse population.
Ricker, C. N., Koff, R. B., Qu, C., Culver, J., Sturgeon, D., Kingham, K. E., … Idos, G. E. (2018). Patient communication of cancer genetic test results in a diverse population. Translational Behavioral Medicine, 8(1), 85–94.

Trends in Cancer Survival by Health Insurance Status in California From 1997 to 2014
Ellis, L., Canchola, A. J., Spiegel, D., Ladabaum, U., Haile, R., & Gomez, S. L. (2018). Trends in Cancer Survival by Health Insurance Status in California From 1997 to 2014. JAMA ONCOLOGY, 4(3), 317–23.

Worldwide Practice Patterns in Lynch Syndrome Diagnosis and Management, Based on Data From the International Mismatch Repair Consortium.
Pan, J. Y., Haile, R. W., Templeton, A., Macrae, F., Qin, F. F., Sundaram, V., & Ladabaum, U. (2018). Worldwide Practice Patterns in Lynch Syndrome Diagnosis and Management, Based on Data From the International Mismatch Repair Consortium. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics
Ellis, L., Canchola, A. J., Spiegel, D., Ladabaum, U., Haile, R., & Gomez, S. L. (2018). Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics. JOURNAL OF CLINICAL ONCOLOGY, 36(1), 25-+.

Low Rates of Gastrointestinal and Non-Gastrointestinal Complications for Screening or Surveillance Colonoscopies in a Population-Based Study
Wang, L., Mannalithara, A., Singh, G., & Ladabaum, U. (2018). Low Rates of Gastrointestinal and Non-Gastrointestinal Complications for Screening or Surveillance Colonoscopies in a Population-Based Study. GASTROENTEROLOGY, 154(3), 540-+.

Low Prevalence of Criteria for Early Screening in Young-Onset Colorectal Cancer
Chen, F. W., Sundaram, V., Chew, T. A., & Ladabaum, U. (2017). Low Prevalence of Criteria for Early Screening in Young-Onset Colorectal Cancer. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 53(6), 933–34.

Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.
Ladabaum, U., Mannalithara, A., Brill, J. V., Levin, Z., & Bundorf, M. K. (2018). Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare. The American Journal of Gastroenterology.

Occult blood in faeces: a window into health beyond the colorectum?
Ladabaum, U. (2018). Occult blood in faeces: a window into health beyond the colorectum? Gut.

Tumor Molecular Testing Guides Anti-PD-1 Therapy and Provides Evidence for Pathogenicity of Mismatch Repair Variants.
Patel, S. A., Longacre, T. A., Ladabaum, U., Lebensohn, A., Lin, A. Y., & Haraldsdottir, S. (2018). Tumor Molecular Testing Guides Anti-PD-1 Therapy and Provides Evidence for Pathogenicity of Mismatch Repair Variants. The Oncologist.

Incidence of interval colorectal cancer attributable to an endoscopist in clinical practice
Ertem, F. U., Ladabaum, U., Mehrotra, A., Tehranian, S., Shi, Z., Saul, M., … Schoen, R. E. (2018). Incidence of interval colorectal cancer attributable to an endoscopist in clinical practice. GASTROINTESTINAL ENDOSCOPY, 88(4), 705-+.

Potential Intended and Unintended Consequences of Recommending Initiation of Colorectal Cancer Screening at Age 45 Years
Liang, P. S., Allison, J., Ladabaum, U., Martinez, M. E., Murphy, C. C., Schoen, R. E., … Gupta, S. (2018). Potential Intended and Unintended Consequences of Recommending Initiation of Colorectal Cancer Screening at Age 45 Years. GASTROENTEROLOGY, 155(4), 950–54.

Colonoscopy quality requisites for selecting surveillance intervals: A World Endoscopy Organization Delphi Recommendation.
Jover, R., Dekker, E., Schoen, R. E., Hassan, C., Pellise, M., & Ladabaum, U. (2018). Colonoscopy quality requisites for selecting surveillance intervals: A World Endoscopy Organization Delphi Recommendation. Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society.

The Case for a Multitarget Stool DNA Test: A Closer Look at the Cost Effectiveness Model Reply
Ladabaum, U., & Mannalithara, A. (2017). The Case for a Multitarget Stool DNA Test: A Closer Look at the Cost Effectiveness Model Reply. GASTROENTEROLOGY, 152(6), 1621-+.

Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample.
Knight, S. J., Mohamed, A. F., Marshall, D. A., Ladabaum, U., Phillips, K. A., & Walsh, J. M. (2015). Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample. Medical Decision Making : an International Journal of the Society for Medical Decision Making.

Key emerging themes for assessing the cost-effectiveness of reporting incidental findings
Phillips, K. A., Ladabaum, U., Pletcher, M. J., Marshall, D. A., & Douglas, M. P. (2015). Key emerging themes for assessing the cost-effectiveness of reporting incidental findings. GENETICS IN MEDICINE, 17(4), 314–15.

Identifying Persons with Lynch Syndrome: Why and How?
Ladabaum, U. (2014). Identifying Persons with Lynch Syndrome: Why and How? DIGESTIVE DISEASES AND SCIENCES, 59(12), 2841–44.

Endoscopic optical biopsy: when we look, what can we see?
Ladabaum, U. (2013). Endoscopic optical biopsy: when we look, what can we see? LANCET ONCOLOGY, 14(13), 1253–54.

Moving From Current Guidelines To Personalized Colorectal Cancer Screening: Opportunities and Challenges.
Robertson, D. J., & Ladabaum, U. (2018). Moving From Current Guidelines To Personalized Colorectal Cancer Screening: Opportunities and Challenges. Gastroenterology.

Response.
Ertem, F. U., Ladabaum, U., & Schoen, R. E. (2019). Response. Gastrointestinal Endoscopy, 89(4), 896–97.

How I do it: Does this cost-effectiveness analysis convince me about screening for Barrett's esophagus?
Ladabaum, U. (2019). How I do it: Does this cost-effectiveness analysis convince me about screening for Barrett's esophagus? Gastrointestinal Endoscopy, 89(4), 723–25.

Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk
Idos, G. E., Kurian, A. W., Ricker, C., Sturgeon, D., Culver, J. O., Kingham, K. E., … Mukherjee, B. (2019). Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk. JCO Precision Oncology.

Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment.
Kurian, A. W., Hare, E. E., Mills, M. A., Kingham, K. E., McPherson, L., Whittemore, A. S., … Ford, J. M. (2014). Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology.

Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review.
Douglas, M. P., Ladabaum, U., Pletcher, M. J., Marshall, D. A., & Phillips, K. A. (2016). Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 18(2), 111–6.

Colorectal Cancer Knowledge, Risk Perception, and Screening Inclination Among Previously Unscreened Adults
Yen, T., Asiimwe, E., Qin, F., Sundaram, V., Storage, T., & Ladabaum, U. (2018). Colorectal Cancer Knowledge, Risk Perception, and Screening Inclination Among Previously Unscreened Adults. AMERICAN JOURNAL OF GASTROENTEROLOGY, 113, S163–S164.

Trends in Incidence and Stage at Diagnosis of Colorectal Cancer in Adults Aged 40 Through 49 Years, 1975-2015.
Meester, R. G., Mannalithara, A., Lansdorp-Vogelaar, I., & Ladabaum, U. (2019). Trends in Incidence and Stage at Diagnosis of Colorectal Cancer in Adults Aged 40 Through 49 Years, 1975-2015. JAMA, 321(19), 1933–34.

Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare
Ladabaum, U., Mannalithara, A., Brill, J. V., Levin, Z., & Bundorf, M. K. (2018). Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare. AMERICAN JOURNAL OF GASTROENTEROLOGY, 113(12), 1836–47.

Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study.
Li, D., Hoodfar, E., Jiang, S.-F., Udaltsova, N., Pham, N. P., Jodesty, Y., … Bergoffen, J. A. (2019). Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study. Annals of Internal Medicine.

Effectiveness and cost of organized outreach for colorectal cancer screening: A Randomized Controlled Trial.
Somsouk, M., Rachocki, C., Mannalithara, A., Garcia, D., Laleau, V., Grimes, B., … Ladabaum, U. (2019). Effectiveness and cost of organized outreach for colorectal cancer screening: A Randomized Controlled Trial. Journal of the National Cancer Institute.

Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years
Ladabaum, U., Mannalithara, A., Meester, R. G. S., Gupta, S., & Schoen, R. E. (2019). Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years. GASTROENTEROLOGY, 157(1), 137–48.

Strategies for Colorectal Cancer Screening.
Ladabaum, U., Dominitz, J. A., Kahi, C., & Schoen, R. E. (2019). Strategies for Colorectal Cancer Screening. Gastroenterology.

What is Lynch-like Syndrome and How Should we Manage It?
Ladabaum, U. (2019). What is Lynch-like Syndrome and How Should we Manage It? Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

You Should Get Screened for Colon Cancer, Really.
Ladabaum, U. (2019). You Should Get Screened for Colon Cancer, Really. JAMA Network Open, 2(8), e1910452.

High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.
Meester, R. G., Lansdorp-Vogelaar, I., Winawer, S. J., Zauber, A. G., Knudsen, A. B., & Ladabaum, U. (2019). High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis. Annals of Internal Medicine.

Preventive surgery after multiplex genetic panel testing (MGPT)
Idos, G., Kurian, A. W., Ricker, C., Sturgeon, D., Culver, J., Kingham, K., … Gruber, S. B. (2019). Preventive surgery after multiplex genetic panel testing (MGPT). JOURNAL OF CLINICAL ONCOLOGY, 37(15).

Reply to GASTRO-D-19-00808.
Ladabaum, U., Mannalithara, A., Meester, R. G., Gupta, S., & Schoen, R. E. (2019). Reply to GASTRO-D-19-00808. Gastroenterology.

When Experts Fail: Use of a Short Turning Radius Colonoscope Facilitates Successful Completion of Colonoscopy in Patients with Bowel Fixity.
Girotra, M., Sethi, S., Barakat, M. T., Huang, R. J., Friedland, S., Ladabaum, U., & Banerjee, S. (2019). When Experts Fail: Use of a Short Turning Radius Colonoscope Facilitates Successful Completion of Colonoscopy in Patients with Bowel Fixity. Digestive Diseases and Sciences.

Clinical and Economic Impact of Tailoring Screening to Predicted Colorectal Cancer Risk: A Decision Analytic Modeling Study.
Ladabaum, U., Mannalithara, A., Mitani, A., & Desai, M. (2019). Clinical and Economic Impact of Tailoring Screening to Predicted Colorectal Cancer Risk: A Decision Analytic Modeling Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology.

The case for philanthropic investment to increase colorectal cancer screening rates: A novel paradigm to address a public health challenge.
Carmeli, A., Dranikoff, L., Kundu, A., & Ladabaum, U. (2019). The case for philanthropic investment to increase colorectal cancer screening rates: A novel paradigm to address a public health challenge. Cancer Medicine.

Intensity of Surveillance for Patients With Colorectal Adenomas.
Meester, R. G., Lansdorp-Vogelaar, I., Winawer, S. J., Zauber, A. G., Knudsen, A. B., & Ladabaum, U. (2020). Intensity of Surveillance for Patients With Colorectal Adenomas. Annals of Internal Medicine, 172(6), 442.

Sessile serrated polyps and colorectal cancer mortality.
Meester, R. G., & Ladabaum, U. (2020). Sessile serrated polyps and colorectal cancer mortality. The Lancet. Gastroenterology & Hepatology.

Prevalence and Clinical Features of Sessile Serrated Polyps: A Systematic Review.
Meester, R. G., van Herk, M. M., Lansdorp-Vogelaar, I., & Ladabaum, U. (2020). Prevalence and Clinical Features of Sessile Serrated Polyps: A Systematic Review. Gastroenterology.

The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution.
Rozenblatt-Rosen, O., Regev, A., Oberdoerffer, P., Nawy, T., Hupalowska, A., Rood, J. E., … Williams, E. H. (2020). The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution. Cell, 181(2), 236–49.

A nationwide analysis of readmission rates after colorectal cancer surgery in the US in the Era of the Affordable Care Act.
Kim, J. W., Mannalithara, A., Sehgal, M., Mithal, A., Singh, G., & Ladabaum, U. (2020). A nationwide analysis of readmission rates after colorectal cancer surgery in the US in the Era of the Affordable Care Act. American Journal of Surgery.

Cost-Effectiveness of Current Colorectal Cancer Screening Tests.
Ladabaum, U. (2020). Cost-Effectiveness of Current Colorectal Cancer Screening Tests. Gastrointestinal Endoscopy Clinics of North America, 30(3), 479–97.

AGA White Paper: Roadmap for the Future of Colorectal Cancer Screening in the United States.
Melson, J. E., Imperiale, T. F., Itzkowitz, S. H., Llor, X., Kochman, M. L., Grady, W. M., … Dey, N. (2020). AGA White Paper: Roadmap for the Future of Colorectal Cancer Screening in the United States. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Advanced Notification Calls Prior to Mailed Fecal Immunochemical Test in Previously Screened Patients: a Randomized Controlled Trial.
Lee, B., Patel, S., Rachocki, C., Issaka, R., Vittinghoff, E., Shapiro, J. A., … Somsouk, M. (2020). Advanced Notification Calls Prior to Mailed Fecal Immunochemical Test in Previously Screened Patients: a Randomized Controlled Trial. Journal of General Internal Medicine.

Life After May 25.
Ladabaum, U. (2020). Life After May 25. Annals of Internal Medicine.

Randomized Controlled Trial of Personalized Colorectal Cancer Risk Assessment vs Education to Promote Screening Uptake.
Yen, T., Qin, F. F., Sundaram, V., Asiimwe, E., Storage, T., & Ladabaum, U. (2020). Randomized Controlled Trial of Personalized Colorectal Cancer Risk Assessment vs Education to Promote Screening Uptake. The American Journal of Gastroenterology.

Risk of ambulatory colonoscopy in patients with cirrhosis: a propensity-score matched cohort study.
Huang, R. J., Banerjee, S., Friedland, S., & Ladabaum, U. (2020). Risk of ambulatory colonoscopy in patients with cirrhosis: a propensity-score matched cohort study. Endoscopy International Open, 8(10), E1495–E1501.

Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients.
Culver, J. O., Ricker, C. N., Bonner, J., Kidd, J., Sturgeon, D., Hodan, R., … Idos, G. E. (2020). Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients. Cancer.

Colorectal Cancer Incidence after Colonoscopy at Ages 45-49 or 50-54 Years.
Sehgal, M., Ladabaum, U., Mithal, A., Singh, H., Desai, M., & Singh, G. (2021). Colorectal Cancer Incidence after Colonoscopy at Ages 45-49 or 50-54 Years. Gastroenterology.

Doing our best to do no harm.
Ladabaum, U. (2021). Doing our best to do no harm. Endoscopy, 53(5), 509–10.

Adenoma and Serrated Lesion Detection by Colonoscopy Indication: The ADR-ESS (ADR Extended to all Screening/Surveillance) Score.
Ladabaum, U., Shepard, J., & Mannalithara, A. (2021). Adenoma and Serrated Lesion Detection by Colonoscopy Indication: The ADR-ESS (ADR Extended to all Screening/Surveillance) Score. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Hereditary inflammatory fibroid polyps caused by germline pathogenic variants in PDGFRA: Refining PDGFRA-mutation syndrome.
Hodan, R., Charville, G. W., & Ladabaum, U. (2021). Hereditary inflammatory fibroid polyps caused by germline pathogenic variants in PDGFRA: Refining PDGFRA-mutation syndrome. Cancer Genetics, 256-257, 106–109.

Developing and Deploying an Automated Quality Reporting System in Your Practice: Learning From the Stanford Colonoscopy Quality Assurance Program.
Ladabaum, U., Shepard, J., & Mannalithara, A. (2021). Developing and Deploying an Automated Quality Reporting System in Your Practice: Learning From the Stanford Colonoscopy Quality Assurance Program. The American Journal of Gastroenterology, 116(7), 1365–1370.

Increased Colorectal Cancer Screening Sustained with Mailed Fecal Immunochemical Test Outreach.
Lee, B., Keyes, E., Rachocki, C., Grimes, B., Chen, E., Vittinghoff, E., … Somsouk, M. (2021). Increased Colorectal Cancer Screening Sustained with Mailed Fecal Immunochemical Test Outreach. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk.
Idos, G. E., Kurian, A. W., Ricker, C., Sturgeon, D., Culver, J. O., Kingham, K. E., … Gruber, S. B. (2019). Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk. JCO Precision Oncology, 3.

Subtle endoscopic manifestations of diffuse signet cell gastric adenocarcinoma in patients with CDH1 mutations.
Ladabaum, U., Ford, J. M., Poultsides, G., & Norton, J. (2021). Subtle endoscopic manifestations of diffuse signet cell gastric adenocarcinoma in patients with CDH1 mutations. Gastrointestinal Endoscopy.

The Stanford Colonoscopy Quality Assurance Program: Lessons from the intersection of quality improvement and clinical research.
Ladabaum, U. (2021). The Stanford Colonoscopy Quality Assurance Program: Lessons from the intersection of quality improvement and clinical research. Gastroenterology.

Age-Specific Rates and Time-Courses of Gastrointestinal and Nongastrointestinal Complications Associated With Screening/Surveillance Colonoscopy.
Ladabaum, U., Mannalithara, A., Desai, M., Sehgal, M., & Singh, G. (2021). Age-Specific Rates and Time-Courses of Gastrointestinal and Nongastrointestinal Complications Associated With Screening/Surveillance Colonoscopy. The American Journal of Gastroenterology.

Potential effects of lowering colorectal cancer screening age to 45 years on colonoscopy demand, case mix and adenoma detection rate.
Crockett, S. D., & Ladabaum, U. (2021). Potential effects of lowering colorectal cancer screening age to 45 years on colonoscopy demand, case mix and adenoma detection rate. Gastroenterology.

Counting Advanced Pre-Cancerous Lesions as True Positives When Determining Colorectal Cancer Screening Test Specificity.
Ladabaum, U., Church, T. R., Feng, Z., Ransohoff, D. F., & Schoen, R. E. (2022). Counting Advanced Pre-Cancerous Lesions as True Positives When Determining Colorectal Cancer Screening Test Specificity. Journal of the National Cancer Institute.

Surgery for Hereditary Diffuse Gastric Cancer: Long-Term Outcomes.
Forrester, J. D., Foster, D., Ford, J. M., Longacre, T. A., Ladabaum, U., Fry, S., & Norton, J. A. (2022). Surgery for Hereditary Diffuse Gastric Cancer: Long-Term Outcomes. Cancers, 14(3).

MITI minimum information guidelines for highly multiplexed tissue images.
Schapiro, D., Yapp, C., Sokolov, A., Reynolds, S. M., Chen, Y.-A., Sudar, D., … Sorger, P. K. (2022). MITI minimum information guidelines for highly multiplexed tissue images. Nature Methods, 19(3), 262–267.

Somatic tumor testing implications for Lynch syndrome germline genetic testing.
Barrus, K., Purington, N., Chun, N., Ladabaum, U., & Ford, J. M. (2022). Somatic tumor testing implications for Lynch syndrome germline genetic testing. Cancer Genetics, 264-265, 16–22.

Fulfilling the promise of colorectal cancer screening.
Ladabaum, U. (2022). Fulfilling the promise of colorectal cancer screening. The Lancet. Gastroenterology & Hepatology.

Adenoma and Sessile Serrated Lesion Detection Rates at Screening Colonoscopy for Ages 45-49 Years vs. Older Ages Since the Introduction of New Colorectal Cancer Screening Guidelines.
Ladabaum, U., Shepard, J., & Mannalithara, A. (2022). Adenoma and Sessile Serrated Lesion Detection Rates at Screening Colonoscopy for Ages 45-49 Years vs. Older Ages Since the Introduction of New Colorectal Cancer Screening Guidelines. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

GA White Paper: Challenges and Gaps in Innovation for the Performance of Colonoscopy for Screening and Surveillance of Colorectal Cancer.
Komanduri, S., Dominitz, J. A., Rabeneck, L., Kahi, C., Ladabaum, U., Imperiale, T. F., … Muthusamy, V. R. (2022). GA White Paper: Challenges and Gaps in Innovation for the Performance of Colonoscopy for Screening and Surveillance of Colorectal Cancer. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Reducing the Burden of Colorectal Cancer: AGA Position Statements.
Lieberman, D., Ladabaum, U., Brill, J. V., May, F. P., Kim, L. S., Murphy, C., … Teixeira, K. (2022). Reducing the Burden of Colorectal Cancer: AGA Position Statements. Gastroenterology.

Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer.
Becker, W. R., Nevins, S. A., Chen, D. C., Chiu, R., Horning, A. M., Guha, T. K., … Greenleaf, W. J. (2022). Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer. Nature Genetics.

Cost-effectiveness of earlier or more intensive colorectal cancer screening in overweight and obese patients.
Yeoh, A., Mannalithara, A., & Ladabaum, U. (2022). Cost-effectiveness of earlier or more intensive colorectal cancer screening in overweight and obese patients. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

COVID-19 PANDEMIC-RELATED COLORECTAL CANCER SCREENING DELAYS IMPACT UNSCREENED OLDER ADULTS THE MOST, BUT MITIGATION STRATEGIES EXIST.
Sinha, S., Li, Z., Bar-Mashiah, A., Ladabaum, U., & Sharaf, R. N. (2022). COVID-19 PANDEMIC-RELATED COLORECTAL CANCER SCREENING DELAYS IMPACT UNSCREENED OLDER ADULTS THE MOST, BUT MITIGATION STRATEGIES EXIST. Gastroenterology.

Risk of Proximal Gastrointestinal Cancer after Positive Fecal Immunochemical Test.
Zhou, M. J., Singh, G., Hwang, J. H., & Ladabaum, U. (2022). Risk of Proximal Gastrointestinal Cancer after Positive Fecal Immunochemical Test. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Computer-aided detection of polyps does not improve colonoscopist performance in a pragmatic implementation trial.
Ladabaum, U., Shepard, J., Weng, Y., Desai, M., Singer, S. J., & Mannalithara, A. (2022). Computer-aided detection of polyps does not improve colonoscopist performance in a pragmatic implementation trial. Gastroenterology.

RISK FACTORS FOR METACHRONOUS COLORECTAL CANCER OR ADVANCED ADENOMAS AFTER ENDOSCOPIC RESECTION OF HIGH-RISK ADENOMAS.
Baile-Maxia, S., Mangas-Sanjuan, C., Ladabaum, U., Hassan, C., Rutter, M. D., Bretthauer, M., … Jover, R. (2022). RISK FACTORS FOR METACHRONOUS COLORECTAL CANCER OR ADVANCED ADENOMAS AFTER ENDOSCOPIC RESECTION OF HIGH-RISK ADENOMAS. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Clinical implications of conflicting variant interpretations in the cancer genetics clinic.
Zukin, E., Culver, J. O., Liu, Y., Yang, Y., Ricker, C. N., Hodan, R., … Idos, G. E. (2023). Clinical implications of conflicting variant interpretations in the cancer genetics clinic. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 100837.

Colorectal cancer risk prediction to tailor screening: Will we embrace it or KISS it goodbye?
Ladabaum, U., & Ko, C. W. (2023). Colorectal cancer risk prediction to tailor screening: Will we embrace it or KISS it goodbye? Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Impact of race/ethnicity and socioeconomic status on incident and prevalent esophageal cancer in patients with Barrett's esophagus.
Zhou, M. J., Ladabaum, U., Triadafilopoulos, G., & Clarke, J. O. (2023). Impact of race/ethnicity and socioeconomic status on incident and prevalent esophageal cancer in patients with Barrett's esophagus. Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus.

An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles.
Bresalier, R. S., Senore, C., Young, G. P., Allison, J., Benamouzig, R., Benton, S., … Winawer, S. J. (2023). An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles. Gut.

Does Screening Colonoscopy Have a Future in the United States?
Rex, D. K., Ladabaum, U., Anderson, J. C., Shaukat, A., Butterly, L. F., Dominitz, J. A., … Hassan, C. (2023). Does Screening Colonoscopy Have a Future in the United States? Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

BELIEFS AND ATTITUDES ABOUT ARTIFICIAL INTELLIGENCE (AI) AMONG COLONOSCOPIST PARTICIPANTS IN A PRAGMATIC IMPLEMENTATION TRIAL OF COMPUTER-AIDED DETECTION (CADE) OF POLYPS THAT DID NOT REPLICATE THE POSITIVE RESULTS OF RANDOMIZED TRIALS
Ladabaum, U., Mannalithara, A., Weng, Y., Shaw, B., Olsen, E., Watkins, K., … Singer, S. (2023). BELIEFS AND ATTITUDES ABOUT ARTIFICIAL INTELLIGENCE (AI) AMONG COLONOSCOPIST PARTICIPANTS IN A PRAGMATIC IMPLEMENTATION TRIAL OF COMPUTER-AIDED DETECTION (CADE) OF POLYPS THAT DID NOT REPLICATE THE POSITIVE RESULTS OF RANDOMIZED TRIALS. GASTROINTESTINAL ENDOSCOPY. MOSBY-ELSEVIER.

ENDOSCOPIST ADENOMA DETECTION RATE IS ASSOCIATED WITH DETECTION OF COLORECTAL CANCER AT COLONOSCOPY PERFORMED FOR SCREENING OR EVALUATION OF ABNORMAL STOOL TEST
Dominitz, J., Holub, J., Issaka, R., Ko, C., Robertson, D., & Ladabaum, U. (2023). ENDOSCOPIST ADENOMA DETECTION RATE IS ASSOCIATED WITH DETECTION OF COLORECTAL CANCER AT COLONOSCOPY PERFORMED FOR SCREENING OR EVALUATION OF ABNORMAL STOOL TEST. GASTROINTESTINAL ENDOSCOPY. MOSBY-ELSEVIER.

The Time Has Come to Adopt the Sessile Serrated Lesion Detection Rate as a Quality Metric.
Ladabaum, U. (2023). The Time Has Come to Adopt the Sessile Serrated Lesion Detection Rate as a Quality Metric. The American Journal of Gastroenterology.

NordICC's 10-year interim results are unexpected, and inconsistent with modeling predictions.
Ladabaum, U., Schoen, R. E., & Meester, R. (2023). NordICC's 10-year interim results are unexpected, and inconsistent with modeling predictions. Gastroenterology.

Artificial intelligence-assisted colonoscopy in real-world clinical practice: A systematic review and meta-analysis.
Wei, M. T., Fay, S., Yung, D., Ladabaum, U., & Kopylov, U. (2023). Artificial intelligence-assisted colonoscopy in real-world clinical practice: A systematic review and meta-analysis. Clinical and Translational Gastroenterology.

Colorectal cancer screening at age 45 years in Israel: Cost-effectiveness and global implications.
Half, E. E., Levi, Z., Mannalithara, A., Leshno, M., Ben-Aharon, I., Abu-Freha, N., … Ladabaum, U. (2024). Colorectal cancer screening at age 45 years in Israel: Cost-effectiveness and global implications. Cancer.

Prevalence of Gastric Precursor Lesions in Countries with Differential Gastric Cancer Burden: A Systematic Review & Meta-Analysis.
Mülder, D. T., Hahn, A. I., Huang, R. J., Zhou, M. J., Blake, B., Omofuma, O., … Laszkowska, M. (2024). Prevalence of Gastric Precursor Lesions in Countries with Differential Gastric Cancer Burden: A Systematic Review & Meta-Analysis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Of Humans and Machines in Endoscopy: Flying Solo, Instrument-Aided, or on Autopilot?
Ladabaum, U. (2024). Of Humans and Machines in Endoscopy: Flying Solo, Instrument-Aided, or on Autopilot? Gastroenterology.

Comparative Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With Blood-Based Biomarkers (Liquid Biopsy) vs Fecal Tests or Colonoscopy.
Ladabaum, U., Mannalithara, A., Weng, Y., Schoen, R. E., Dominitz, J. A., Desai, M., & Lieberman, D. (2024). Comparative Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With Blood-Based Biomarkers (Liquid Biopsy) vs Fecal Tests or Colonoscopy. Gastroenterology.

RISK FACTORS FOR METACHRONOUS COLORECTAL CANCER OR ADVANCED LESIONS AFTER ENDOSCOPIC RESECTION OF SERRATED POLYPS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Baile-Maxía, S., Mangas-Sanjuán, C., Ladabaum, U., Ardila, C. S., Sala-Miquel, N., Hassan, C., … Jover, R. (2024). RISK FACTORS FOR METACHRONOUS COLORECTAL CANCER OR ADVANCED LESIONS AFTER ENDOSCOPIC RESECTION OF SERRATED POLYPS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastrointestinal Endoscopy.

Will computer-aided detection of polyps decrease colorectal cancer incidence and mortality?
Ladabaum, U. (2024). Will computer-aided detection of polyps decrease colorectal cancer incidence and mortality? Endoscopy.

Generation of two induced pluripotent stem cell lines from patients with Li-Fraumeni Syndrome carrying TP53 mutation.
Sun, J., Ren, L., Canel Rivero, G., Xu, L., Ladabaum, U., & C Wu, J. (2024). Generation of two induced pluripotent stem cell lines from patients with Li-Fraumeni Syndrome carrying TP53 mutation. Stem Cell Research, 81, 103527.

Adherence to Recommendations for Repeat Surveillance After Publication of New Postpolypectomy Guidelines.
Rosas, U. S., Pan, J. Y., Sundaram, V., Su, A., Fazal, M., Dinh, P., & Ladabaum, U. (2023). Adherence to Recommendations for Repeat Surveillance After Publication of New Postpolypectomy Guidelines. Gastro Hep Advances, 2(1), 132–143.

Quality Indicators for Colonoscopy.
Rex, D. K., Anderson, J. C., Butterly, L. F., Day, L. W., Dominitz, J. A., Kaltenbach, T., … Shaheen, N. J. (2024). Quality Indicators for Colonoscopy. The American Journal of Gastroenterology.

Quality indicators for colonoscopy.
Rex, D. K., Anderson, J. C., Butterly, L. F., Day, L. W., Dominitz, J. A., Kaltenbach, T., … Shaheen, N. J. (2024). Quality indicators for colonoscopy. Gastrointestinal Endoscopy.

Reply to Aziz et al.
Ladabaum, U., Mannalithara, A., Schoen, R. E., Dominitz, J. A., & Lieberman, D. (2024). Reply to Aziz et al. Gastroenterology.

Impact of the serrated pathway on the simulated comparative effectiveness of colorectal cancer screening tests.
Meester, R. G., & Ladabaum, U. (2024). Impact of the serrated pathway on the simulated comparative effectiveness of colorectal cancer screening tests. JNCI Cancer Spectrum.

Global Progression Rates of Precursor Lesions for Gastric Cancer: A Systematic Review and Meta-Analysis.
Hahn, A. I., Mülder, D. T., Huang, R. J., Zhou, M. J., Blake, B., Omofuma, O., … Laszkowska, M. (2024). Global Progression Rates of Precursor Lesions for Gastric Cancer: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Specializing In

Gastrointestinal Genetics
Gastrointestinal Oncology
General Gastroenterology
Heartburn
Other endoscopic procedures
Upper GI endoscopy

Practice Locations

Digestive Health Center in Palo Alto (Endoscopy Suite) Stanford, CA

Stanford, CA

Digestive Health Center in Palo Alto (Endoscopy Suite)

300 Pasteur Drive, Ground Floor

Stanford , CA 94305

(650) 736-5555

More Clinic Information

GI Cancer Prevention Program in Palo Alto Stanford, CA

Redwood City, CA

Digestive Health Center in Redwood City (Endoscopy Suite)

420 Broadway Street, 3rd Floor

Redwood City , CA 94063

(650) 736-5555

More Clinic Information

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(23 Ratings)

Overall Rating

4.9/5

View Ratings by Category

4.8/5

Friendliness

4.9/5

Explanations

4.9/5

Listens

4.9/5

Care provider's efforts to include you in decisions about your care

4.9/5

Recommended to others

0.0/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(129 reviews)

Dr. Ladabaum took extra time before my visit to consult with colleagues about my condition and get their input on course of treatment. He listened carefully to me during the visit and worked with me on a treatment plan.

Jul 2024

•

Verified SHC Patient

He was good .

Jul 2024

•

Verified SHC Patient

Thoughtful Kind and considerate Extremely knowledgeable

Jun 2024

•

Verified SHC Patient

Uri was very inquisitive and thorough and helpful. He presented information in an easy to understand and objective manner.

Jun 2024

•

Verified SHC Patient

Great visit with Dr. Ladabaum and Rachel today!

Jun 2024

•

Verified SHC Patient

He's an excellent clinican

Apr 2024

•

Verified SHC Patient

Clean facility and the doctor was patient enough to listen to my health concerns.

Apr 2024

•

Verified SHC Patient

Dr Ladabaum was wonderful, thank you!

Apr 2024

•

Verified SHC Patient

Extremely happy with my appointment. Impressed by Dr. URI Ladabaum knowledge,and expertise, communication skills, patience, ability to explain everything clearly,, engaging me in making choice he provided for my care. Just PERFECT.

Apr 2024

•

Verified SHC Patient

Outstanding care.

Mar 2024

•

Verified SHC Patient

A thoughtful, careful, excellent physician who uses medical wisdom and common sense: I APPRECIATE him!

Mar 2024

•

Verified SHC Patient

THE VISIT WAS VERY GOOD & EVERY THING WAS ADDRESSED

Mar 2024

•

Verified SHC Patient

Great, pleasant and very knowledgeable Doctor.

Mar 2024

•

Verified SHC Patient

Very straightforward and helpful

Mar 2024

•

Verified SHC Patient

He is the best doctor in my lifetime.

Feb 2024

•

Verified SHC Patient

Professional, very thorough, generous with information and explanations, very good manners

Feb 2024

•

Verified SHC Patient

Dr. Ladabaum and the other two individuals (Rachel Hodan and Benjamin ?) were extremely engaging with me. Everything was explained in laymans terms. I was offered numerous times to ask questions. I felt a part of the process and I never felt I was being talked at. I would highly recommend Dr. Ladabaum and his staff to anyone who is dealing with the same issue I possibly have.

Feb 2024

•

Verified SHC Patient

He is very trustworthy, knowledgeable, and kind. Iâ€™m very pleased he is my doctor.

Jan 2024

•

Verified SHC Patient

Exceptional care

Aug 2023

•

Verified SHC Patient

Dr. Ladabaum is very compassionate, professional and informative. I appreciate him very much.

Jul 2023

•

Verified SHC Patient

Overall excellent visit, thank you!

Jul 2023

•

Verified SHC Patient

Dr Ladabaum is an exceptional physician.

Jul 2023

•

Verified SHC Patient

He was thorough, candid (which I appreciate), but also very helpful and empathetic. Refreshing indeed.

Jun 2023

•

Verified SHC Patient

Informative, helpful and caring. Thank you

May 2023

•

Verified SHC Patient

He is very knowledgeable and explained everything

May 2023

•

Verified SHC Patient

Excellent appointment. He listened and took notes. He reviewed all my test work and answered all of my questions!!

May 2023

•

Verified SHC Patient

Excellent!

Apr 2023

•

Verified SHC Patient

Very knowledgeable.

Apr 2023

•

Verified SHC Patient

He strikes me as caring but my problem is difficult for any doctor to find a cure.

Mar 2023

•

Verified SHC Patient

Exceptional listening

Mar 2023

•

Verified SHC Patient

Excellent doctor!

Feb 2023

•

Verified SHC Patient

Dr Ladabaum is one of my favorite doctors. He listens to my concerns, asks questions regarding my health and history and presents options for treatment. I am very confident that he provides thorough and knowledgeable care.

Feb 2023

•

Verified SHC Patient

Great doctor, took time to listen and explain the options to his patient very thoroughly.

Feb 2023

•

Verified SHC Patient

Dr. Ladabaum was very thorough, caring and helpful during my visit. His expertise is very evident while still maintaining a warm connection.

Jan 2023

•

Verified SHC Patient

Willing to discuss alternative treatment and concerned for my opinion. Easy to talk with.

Dec 2022

•

Verified SHC Patient

Smart, knowledgeable, thorough and friendly.

Nov 2022

•

Verified SHC Patient

Didnt read background. Unprepared

Nov 2022

•

Verified SHC Patient

Good to meet Dr.Ladabaum,provided excellent service.

Nov 2022

•

Verified SHC Patient

My wife and I were very impressed and happy with Uri

Nov 2022

•

Verified SHC Patient

Dr Uri Ladabaum is an excellent GI Specialist. His knowledge and command of the specialty are amazing!! He asks relevant clever questions about patients' problems with the full intention of reaching a conclusion to offer a solution, advice, or treatment. I had doubts about the interpretations of test results, diagnosis, or line of treatment. Dr. Ladabaum explained all aspects of my concerns and queries very systematically and patiently. He makes you feel comfortable and is willing to address all your concerns. He cares for his patient and gives advice with full confidence and responsibility, a trait that is very rare in medical practice. My son and daughter-in-law have been his patients and think very very highly of him. So do I.

Nov 2022

•

Verified SHC Patient

I felt he Was very knowledgeable, he explained things to be very easily and covered all the bases. I basically felt like I was heard and that they are working towards finding out whatâ€™s going on with me. That Iâ€™m going to have a plan moving forward and that makes me feel confident in my health

Oct 2022

•

Verified SHC Patient

Knowledgeable and approachable

Oct 2022

•

Verified SHC Patient

Thank you for the information.

Oct 2022

•

Verified SHC Patient

Doctor is very responsive to all my questions

Aug 2022

•

Verified SHC Patient

I really like the way Dr. Ladabaum thinks about problems how he analyzes them especially when they are complicated.

Aug 2022

•

Verified SHC Patient

Well done, excellent assistant, thanks.

Aug 2022

•

Verified SHC Patient

Excellent physician.

Aug 2022

•

Verified SHC Patient

Thank you for a really helpful visit!

Jul 2022

•

Verified SHC Patient

Excellent doctor, he explained what we could do, including my options. He listened to my concerns and what I had to say about past medical issues. I like him.

Jul 2022

•

Verified SHC Patient

Dr. Uri Ladabaum is an excellent physician and I (we - he is my husbandâ€™s doctor as well) are very grateful to be under his care. Dr. Ladabaum is thorough, has excellent listening skills, a very warm and approachable manner, explains everything fully and answers any and all questions with care. I have undergone several procedures by Dr. Ladabaum and am very, very pleased and comforted he will be conducting the endoscopy and colonoscopy to be scheduled for me this time. I would be pleased to highly recommend him anytime.

Jul 2022

•

Verified SHC Patient

I like Dr ladabaum a lots, this is my first visiting. He is so detail oriented and patient.

Jul 2022

•

Verified SHC Patient

Dr. Ladabaum is the best!

Jun 2022

•

Verified SHC Patient

Dr. Ladabaum is a thoughtful doctor who has outstanding training and who knows the latest guidelines for treatment. He is one of the best doctors at Stanford.

May 2022

•

Verified SHC Patient

He was knowledgeable with hood listening skills. I had a very productive video meeting with him. am glad I chose him as my GI doctor.

Mar 2022

•

Verified SHC Patient

Heâ€™s a great doctor who listens and addresses each concern.

Mar 2022

•

Verified SHC Patient

Dr. Ladabaum was incredibly helpful, insightful, and kind. He took the time to answer my questions and offered me so much help.

Feb 2022

•

Verified SHC Patient

Excellent. Dr. Ladabaum was very informative of a stomach condition and how best to treat it. Spent sufficient time to explain and answer questions.

Jan 2022

•

Verified SHC Patient

Dr. Ladabaum is an excellent doctor taking care of and following up on my GI issues.

Jan 2022

•

Verified SHC Patient

Good comunication and informative. If there is one thing that I would pass on. The visit felt a little rushed.

Dec 2021

•

Verified SHC Patient

Dr. Ladabaum is phenomenal! The care, attention and professional advise he offers are truly remarkable!

Dec 2021

•

Verified SHC Patient

Dr. Ladaboum provided me with good information on the area we discussed, he seemed to be knowledgeable about on the field and I felt comfortable talking to him.

Dec 2021

•

Verified SHC Patient

Dr. Ladabaum is wonderful! He is very attentive and understanding, and he explains everything perfectly. I'm very happy to be his patient!

Nov 2021

•

Verified SHC Patient

He's great.

Nov 2021

•

Verified SHC Patient

The visit went well.

Nov 2021

•

Verified SHC Patient

Very thoughtful, thorough, objective - thanks

Nov 2021

•

Verified SHC Patient

Dr Ladabaum is excellent, he answered all my questions and concerns clearly. Thanks

Nov 2021

•

Verified SHC Patient

He did an outstanding job of making me feel comfortable. I trust him completely. I believe he is a competent, professional medical doctor. He was the only doctor able to perform my colonscopy. I appreciate his expertise.

Oct 2021

•

Verified SHC Patient

Answered my questions thoroughly and inspired confidence regarding upcoming appointment.

Sep 2021

•

Verified SHC Patient

DR. Ladabaum explained everything with analysis. I am glad to have him.

Sep 2021

•

Verified SHC Patient

Wonderful visit with Dr. Ladabaum. He listened, evaluated the situation, asked me lots of questions and came up with a short term plan which I agreed with.

Aug 2021

•

Verified SHC Patient

I enjoyed meeting you and look forward to working with you to manage my care.

Aug 2021

•

Verified SHC Patient

He was great. Really enjoyed the visit.

Aug 2021

•

Verified SHC Patient

Had a very good visit with dr. Ladabaum.

Aug 2021

•

Verified SHC Patient

I appreciate how clean his descriptions of the procedure were and how direct and honest he was.

Aug 2021

•

Verified SHC Patient

Heâ€™s very knowledgeable and clear. Really liked him.

Jul 2021

•

Verified SHC Patient

First class doctor. Very understanding and easy to understand.

Jul 2021

•

Verified SHC Patient

Many thanks to Dr. Uri Ladabaum! An awesome doctor!!

Jun 2021

•

Verified SHC Patient

Clearly Understood the go ahead plan.

Jun 2021

•

Verified SHC Patient

Dr. L. took time to talk to me, hear my problems, made me feel like I was well cared for. Definitely recommend him.

Oct 2019

•

Verified SHC Patient

Very knowledgeable and professional, super kind, great experience.

Aug 2019

•

Verified SHC Patient

Dr. Ladabaum was amazing - I was seeking a second opinion on my situation and found him extremely clear and easy to talk to - I came away with much deeper understanding of my health status and the best treatment options to consider. He was smart, reassuring, friendly & caring, even though I'm not his patient!

May 2019

•

Verified SHC Patient

Good because of kind.

Apr 2019

•

Verified SHC Patient

First-class treatment in all respects, IMO.

Mar 2019

•

Verified SHC Patient

I especially appreciated the thorough explanation of the available diagnostic options and their advantages and limitations.

Nov 2018

•

Verified SHC Patient

All very attentive so much the personnel doctor, secretary, nurse, etc., etc. Very good treatment.

Nov 2018

•

Verified SHC Patient

Dr. Ladabaum was outstanding. Ability to communicate with patient is exceptional.

Sep 2018

•

Verified SHC Patient

Excellent attention from Dr. Uri Ladabaum.

Sep 2018

•

Verified SHC Patient

Great doctor.

Sep 2018

•

Verified SHC Patient

I was very impressed withDoctor Ladabaum. A very professional, knowledgeable Doctor with great bedside manners.

Sep 2018

•

Verified SHC Patient

High technical skills. - People skills are fair can be cold/unempathetic at times, not interested in patient's details of the symptoms. I'd still go back to this provider for another try.

Aug 2018

•

Verified SHC Patient

Dr. Ladabaum & I had very good rapport. His expertise was very appreciated.

Jul 2018

•

Verified SHC Patient

Drs. were very thorough.

Jun 2018

•

Verified SHC Patient

Doctor didn't seem interested in trying to help me beyond a cursory attempt. I expected far better from Stanford.

May 2018

•

Verified SHC Patient

Peter Levonian & Kim Zayhowski spoke with me at length prior to Dr. Ladabaum and all 3 were outstanding.

May 2018

•

Verified SHC Patient

EXTREMELY IMPRESSIVE.

Mar 2018

•

Verified SHC Patient

Kerry Kingham and Dr. Ladabaum are the best!

Mar 2018

•

Verified SHC Patient

The doctor was friendly, caring and very easy to understand & was definitely helpful in every way.

Mar 2018

•

Verified SHC Patient

Although the doctor was very knowledgeable and thorough, it took forever to book an appointment and once at the hospital, it took a long time to even see the doctor.

Mar 2018

•

Verified SHC Patient

Dr. Ladabaum was excellent.

Feb 2018

•

Verified SHC Patient

A dream care provider.

Sep 2017

•

Verified SHC Patient

Very good.

Aug 2017

•

Verified SHC Patient

Dr. Ladabaum is the consummate physician. His knowledge & kindness are the best any patient could find. I am lucky to be in his care.

Jun 2017

•

Verified SHC Patient

Provider was so easy to follow despite the seriousness of the topic (cancer). He also made me feel so comfortable & he cared what my decision is. Best care this year!!

Mar 2017

•

Verified SHC Patient

Dr. Ladabaum was very good, thoroughly reviewed my case, explained his view and new information that was helpful to me.

Dec 2016

•

Verified SHC Patient

Good.

Dec 2016

•

Verified SHC Patient

Good.

Nov 2016

•

Verified SHC Patient

Perfect.

Nov 2016

•

Verified SHC Patient

Good experience.

Oct 2016

•

Verified SHC Patient

I thought the dr. took a lot of time with me which was exceptional and very much appreciated.

Oct 2016

•

Verified SHC Patient

The care provider is very good. He gave me the time for explanations all my sickness. He is so good provider.

Sep 2016

•

Verified SHC Patient

long appointment bc the doctor took time to talk through all my issues. I especially appreciated that he didn't talk down to me and we weighed pros and cons. Excellent Doctor.

Aug 2016

•

Verified SHC Patient

The Medical information I was provider after surgery was very informative.

Aug 2016

•

Verified SHC Patient

A couldn't ask for a more caring doctor...

Aug 2016

•

Verified SHC Patient

My care provider was extremely patient and overall gave me the best care I've received from a doctor.

Apr 2016

•

Verified SHC Patient

I worked with Dr Ladabaum several years ago when I began my journey treating my medical condition. I am so pleased to have located him again & to be working with him again. He's the best all around!

Mar 2016

•

Verified SHC Patient

I appreciated the doctors honesty and being very direct in a sensitive manner.

Jan 2016

•

Verified SHC Patient

Both trainee & staff doctor were excellent.

Jan 2016

•

Verified SHC Patient

Both Dr. Ladabaum & the genetic counselor were wonderful!

Oct 2015

•

Verified SHC Patient

We are very blessed to have such an excellent doctor, as Dr. Ladabaum. He is a gift to the field of medicine & to his patients.

Sep 2015

•

Verified SHC Patient

Good.

Aug 2015

•

Verified SHC Patient

I get very good talked with the doctor he give me a good explanations for take care myself.

Jul 2015

•

Verified SHC Patient

Dr. Ladabaum and his team are outstanding. I am so lucky to be his patient. His kindness and understand are profound.

Mar 2015

•

Verified SHC Patient

Had no complains at all.

Jan 2015

•

Verified SHC Patient

He hospitalized me that day and I needed to be hospitalized!

Oct 2014

•

Verified SHC Patient

Dr. Ladabaum was excellent, knowledgeable & courteous.

Aug 2014

•

Verified SHC Patient

Dr. Ladabaum is very easy to talk with and I do not feel "rushed" during my appointment.

Jul 2014

•

Verified SHC Patient

Very informative & caring.

Apr 2014

•

Verified SHC Patient

I feel very secure in moving on and putting my health in drs care.

Feb 2014

•

Verified SHC Patient

Was very helpful & encouraging & thorough in assisting me in all the areas of concern & in clarifying my questions.

Dec 2013

•

Verified SHC Patient

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Uri Ladabaum

Gastroenterologist, Geneticist, Cancer geneticist, General gastroenterologist

Get In Touch

Biography

Professional Summary

Education & Certifications

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Digestive Health Center in Palo Alto (Endoscopy Suite) Stanford, CA

Digestive Health Center in Palo Alto (Endoscopy Suite)

GI Cancer Prevention Program in Palo Alto Stanford, CA

GI Cancer Prevention Program in Palo Alto

GI Cancer Prevention Program in Redwood City Redwood City, CA

GI Cancer Prevention Program in Redwood City

General Gastroenterology Clinic in Redwood City Redwood City, CA

General Gastroenterology Clinic in Redwood City

General Gastroenterology Clinic Redwood City, CA

General Gastroenterology Clinic

General Endoscopy Redwood City, CA

General Endoscopy

General Endoscopy Suite in Redwood City Redwood City, CA

General Endoscopy Suite in Redwood City

Advanced Endoscopy in Palo Alto Stanford, CA

Advanced Endoscopy in Palo Alto

Digestive Health Center in Redwood City Redwood City, CA

Digestive Health Center in Redwood City

Digestive Health Center in Redwood City (Endoscopy Suite) Redwood City, CA

Digestive Health Center in Redwood City (Endoscopy Suite)

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(129 reviews)

Referring Physicians

PHYSICIAN HELPLINE